BIO-Europe Fall 2025

Lys Therapeutics is glad to announce attending BIO-Europe in Vienna, Austria (3-5 November 2025).

At Lys Therapeutics, we continue to advance our pipeline-in-a-drug strategy with our lead antibody LYS241, a perfect fit as a standalone treatment or in combination with standard of care in neurovascular and neurodegenerative diseases.

We look forward to discussing our recent progress, exploring new collaborations, and continuing to create long-term value for patients, our partners and stakeholders.

BIOEurope LifeSciences Neuroscience BiotechPartnering LysTherapeutics